| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |